Does GLOFITAMAB Cause Sinus tachycardia? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Sinus tachycardia have been filed in association with GLOFITAMAB (Columvi). This represents 0.9% of all adverse event reports for GLOFITAMAB.
10
Reports of Sinus tachycardia with GLOFITAMAB
0.9%
of all GLOFITAMAB reports
0
Deaths
9
Hospitalizations
How Dangerous Is Sinus tachycardia From GLOFITAMAB?
Of the 10 reports, 9 (90.0%) required hospitalization.
Is Sinus tachycardia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLOFITAMAB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does GLOFITAMAB Cause?
Cytokine release syndrome (415)
Disease progression (183)
Off label use (129)
Death (125)
Neutropenia (109)
Pyrexia (78)
Febrile neutropenia (69)
Covid-19 (62)
Drug ineffective (53)
Immune effector cell-associated neurotoxicity syndrome (45)
What Other Drugs Cause Sinus tachycardia?
CLOZAPINE (598)
QUETIAPINE (593)
BUPROPION (311)
OLANZAPINE (296)
ACETAMINOPHEN (267)
VENLAFAXINE (263)
CYCLOPHOSPHAMIDE (247)
RISPERIDONE (244)
ARIPIPRAZOLE (236)
AMLODIPINE (228)
Which GLOFITAMAB Alternatives Have Lower Sinus tachycardia Risk?
GLOFITAMAB vs GLOFITAMAB-GXBM
GLOFITAMAB vs GLUCAGON
GLOFITAMAB vs GLUCAGON\GLUCAGON\WATER
GLOFITAMAB vs GLUCARPIDASE
GLOFITAMAB vs GLUCOPHAGE